Pages that link to "Q77628640"
Jump to navigation
Jump to search
The following pages link to Antiandrogen withdrawal syndrome with cyproterone acetate (Q77628640):
Displaying 8 items.
- Antiandrogen withdrawal syndrome associated with prostate cancer therapies: incidence and clinical significance (Q33335129) (← links)
- Antiandrogens in prostate cancer (Q33832646) (← links)
- 3 beta-acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity (Q34956743) (← links)
- Switching and withdrawing hormonal agents for castration-resistant prostate cancer. (Q38309205) (← links)
- Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial (Q43229063) (← links)
- Bone alkaline phosphatase serum level predicts the response to antiandrogen withdrawal (Q44103141) (← links)
- Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer (Q46440011) (← links)
- Biochemical and objective response to abiraterone acetate withdrawal: incidence and clinical relevance of a new scenario for castration-resistant prostate cancer (Q85195938) (← links)